National Health Investors earnings beat by $10.28, revenue fell short of estimates
National Health Investors (NYSE: NHI) reported Q3 EPS of $11.47, beating estimates by $10.28, but revenue of $60.65M fell short of expectations. The stock is down 7.14% over 12 months, closing at $71.23. InvestingPro rates its financial health as 'great performance.'
How this was made
The 30-second read
Why it matters
The earnings release is the first report of the quarter's numbers, making it a primary source of new information.
Market read
NHI's earnings surprise could drive short‑term price movement, especially given the revenue miss.
What to watch
Potential cost‑control measures or upcoming portfolio acquisitions that could offset the revenue miss.
Background
The article is a brief earnings summary from Investing.com with promotional content but provides the core financial results.
Ticker impact
National Health Investors reported Q3 EPS of $11.47, $10.28 above estimate, while revenue missed at $60.65M vs $68.55M consensus.
likely pressure as investors price in the revenue shortfall despite the EPS beat
The large EPS surprise is offset by a material revenue miss, which typically leads to a sell‑off in the near term.
Market effects
May signal pressure for other health‑investment REITs if revenue concerns spread.
Limited to U.S. small‑cap investors.
Low, as the company is a niche REIT with modest global exposure.
Counterpoint
The EPS beat could indicate strong underlying profitability, suggesting a buying opportunity if revenue shortfall is temporary.
Key entities
- CompanyNational Health Investors
Health‑care REIT listed on NYSE under ticker NHI.
